Skip to Main Content

Paper Details

Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study.
Int J Cardiol
36
2020
Author NameAffiliation
Paul KhairyMontreal Heart Institute, Universite de Montreal
Alexander R OpotowskyBoston Children's Hospital, Brigham and Women's Hospital
Craig S BrobergOregon Health & Science University Hospital
Gary D WebbCincinnati Children's Hospital Medical Centre
  • 1 - 4

Datasets

Release 1.2